EXPLAINER

'Chicken skin' is harmless and stubborn: what actually smooths keratosis pilaris

The bumps are plugged hair follicles, not dirt or a deficiency. Keratolytics help modestly and temporarily: lactic acid cut lesions 66% and salicylic acid 52% over 12 weeks, but they return when you stop.

Mean reduction in keratosis pilaris lesions after 12 weeks of twice-daily cream10% lactic acid: 66%; 5% salicylic acid: 52%0%35%70%10% lactic acid66%5% salicylic acid52%
Mean reduction in keratosis pilaris lesions after 12 weeks of twice-daily cream
GroupValue (%)
10% lactic acid66
5% salicylic acid52
Mean reduction in keratosis pilaris lesions after 12 weeks of twice-daily cream One randomised trial comparing two keratolytic creams applied to affected skin; improvement faded toward baseline after treatment stopped. Source: Dermatology Research and Practice

The little rough bumps on the backs of the upper arms and thighs — often called "chicken skin" — are keratosis pilaris (KP), and the first useful thing to know is that they are medically harmless. KP is a benign disorder of follicular keratinisation: rough keratotic papules with variable redness around each follicle, most often on the extensor upper arms, thighs and buttocks [s1]. It is not caused by poor washing, and it is not a vitamin deficiency. Knowing what it actually is explains both why it is so common and why nothing scrubs it away for good.

What causes the bumps

Each bump is a hair follicle plugged with retained skin cells. The underlying process is follicular hyperkeratosis with retention keratosis and abnormal desquamation — the shedding of dead cells goes wrong and they pile up at the follicle opening [s1]. This usually happens against a background of dry skin and a weakened epidermal barrier, which is why KP travels with atopic dermatitis, ichthyosis vulgaris and filaggrin-related barrier impairment [s1]. Filaggrin is a protein that helps hold the skin barrier together; when it is in short supply, the barrier leaks water and the follicles clog more easily. That barrier story is the rationale behind every treatment that works: soften the plug, loosen the cells, and hold moisture in the outer skin layer [s1].

What actually helps — and how much

The mainstay is topical keratolytics: alpha hydroxy acids (such as lactic and glycolic acid), beta hydroxy acids (salicylic acid) and urea. A literature review concludes that these remain reasonable first-line, symptom-directed options, with AHAs, BHAs and urea all demonstrating potential benefit [s1]. "Potential benefit" is doing careful work in that sentence — the review is candid that the evidence base is constrained by small sample sizes, heterogeneous outcome measures, limited blinding and short follow-up, with sparse long-term data [s1].

The best single trial gives a sense of the ceiling. Patients were randomised to 10% lactic acid or 5% salicylic acid cream applied twice daily for three months [s2]. At the end, the mean reduction of lesions from baseline was 66% for 10% lactic acid and 52% for 5% salicylic acid, both statistically significant, with improved skin hydration on instrument measurement and only mild, local irritation [s2]. Those are real numbers and a good result. But the same design shows the catch built into KP: the study measured skin again four weeks after treatment stopped, and the condition is one that returns when the keratolytic is withdrawn [s2]. KP is managed, not cured.

Newer approaches target the redness rather than the roughness. A split-body randomised trial injected a non-cross-linked hyaluronic acid compound into KP-affected skin on both upper arms across four sessions; treated areas showed significantly reduced roughness and overall scores against untreated control skin, and 35.71% of patients showed sustained improvement in redness at follow-up [s3]. It is a small, single trial of a procedure, not a bathroom routine, and it does not change the basic picture: the bumps come back without maintenance.

A realistic routine

Put together, the evidence supports a simple, low-cost plan rather than a cure. Gentle washing without harsh scrubbing, a keratolytic cream — lactic acid, urea or salicylic acid — used consistently, and a plain moisturiser to support the barrier is the combination with the best backing [s1][s2]. Improvement takes weeks, is partial, and needs to be kept up; stopping lets the follicles re-plug. Aggressive physical exfoliation and picking tend to inflame the skin and can leave marks, especially on darker skin tones, without fixing the underlying keratinisation. Warm, humid weather often improves the bumps on its own, while dry winter air makes them rougher — a seasonal swing that tracks the barrier-and-dryness mechanism rather than anything you did or failed to do [s1].

KP rarely needs a doctor at all. It often eases on its own with age, and the redness fades faster than the texture. It is worth a professional opinion if the bumps are intensely itchy, widespread, rapidly changing, or if you are unsure whether what you are seeing is KP rather than acne or an infected follicle — but for the classic rough patch on the arms, the honest message is that it is a cosmetic nuisance you can soften, not a disease you need to defeat.

This article is informational and is not medical advice.

Sources

  • [s1] The Effectiveness of Topical Keratolytics (Alpha Hydroxy Acids/Beta Hydroxy Acids/Urea) in Treating Keratosis Pilaris: A Review of the Literature — Cureus, 31 December 2025. https://doi.org/10.7759/cureus.100507
  • [s2] Epidermal permeability barrier in the treatment of keratosis pilaris — Dermatology Research and Practice, 24 February 2015. https://doi.org/10.1155/2015/205012
  • [s3] Efficacy and safety of non-cross-linked hyaluronic acid compound in the treatment of keratosis pilaris: A split-body randomized clinical trial — Journal of Cosmetic Dermatology, 23 August 2024. https://doi.org/10.1111/jocd.16532

Sources

  1. The Effectiveness of Topical Keratolytics (Alpha Hydroxy Acids/Beta Hydroxy Acids/Urea) in Treating Keratosis Pilaris: A Review of the Literature — Cureus , December 31, 2025
  2. Epidermal permeability barrier in the treatment of keratosis pilaris — Dermatology Research and Practice , February 24, 2015
  3. Efficacy and safety of non-cross-linked hyaluronic acid compound in the treatment of keratosis pilaris: A split-body randomized clinical trial — Journal of Cosmetic Dermatology , August 23, 2024
Related coverage